BOSTON SCIENTIFIC CORP (BSX) Stock Price, Quote, News and Summary
NYSE:BSX - New York Stock Exchange, Inc. - US1011371077 - Common Stock
BSX Quote and Key Statistics
BOSTON SCIENTIFIC CORP
NYSE:BSX (1/17/2025, 8:04:01 PM)
Premarket: 99.09 +0.43 (+0.44%)98.66
+0.49 (+0.5%)
BSX Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.27% | ||
| ROA | 4.71% | ||
| ROE | 8.66% | ||
| Debt/Equity | 0.45 |
BSX Performance and Technical Analysis
BSX Ownership and Analysts
BSX Latest News and Analysis
Which S&P500 stocks are moving on Wednesday?
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
BOSTON SCIENTIFIC CORP (NYSE:BSX) showing some interesting technicals. Here's why.
In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP.
Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSE™ Pulsed Field Ablation (PFA) System* and the...
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.
About BSX
Company Profile
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 48,000 full-time employees. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. The company also owns the transcarotid artery revascularization (TCAR) platform.
Company Info
BOSTON SCIENTIFIC CORP
300 Boston Scientific Way
Marlborough MASSACHUSETTS 01752 US
CEO: Michael F. Mahoney
Employees: 48000
Company Website: https://www.bostonscientific.com/en-US/Home.html
Investor Relations: https://investors.bostonscientific.com
Phone: 15086834000
BSX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 88.19 | 211.09B | ||
| ABT | ABBOTT LABORATORIES | 25.11 | 196.83B | ||
| SYK | STRYKER CORP | 32.94 | 146.17B | ||
| MDT | MEDTRONIC PLC | 16.78 | 112.94B | ||
| BDX | BECTON DICKINSON AND CO | 18.04 | 68.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.13 | 41.16B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.08 | 38.72B | ||
| RMD | RESMED INC | 28.92 | 35.20B | ||
| IDXX | IDEXX LABORATORIES INC | 38.29 | 34.33B | ||
| DXCM | DEXCOM INC | 49.64 | 32.96B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.4 | 24.25B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 13.89 | 21.81B |